Extracellular microvesicles from patients with antiphospholipid syndrome carry antigenic targets and promote endothelial cell activation <i>in vitro</i>
Antiphospholipid syndrome (APS) is characterised by thrombosis, recurrent miscarriages and the stable presence of antiphospholipid antibodies (aPLs). Circulating aPLs can activate molecular mechanisms that may promote the activation of various cell types, particularly endothelial cells. Recently, e...
Shranjeno v:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2026-02-01
|
| Serija: | Haematologica |
| Online dostop: | https://haematologica.org/article/view/13167 |
| Oznake: |
Brez oznak, prvi označite!
|
